IRMD vs. SPY

In the year-to-date period, IRMD achieves a 5.89% return, which is significantly higher than SPY's 0.87% return. Both investments have delivered pretty close results over the past 10 years, with IRMD having a 12.16% annualized return and SPY not far ahead at 12.73%.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for IRadimed Corporation (IRMD) and SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current IRMD Sharpe Ratio is 1.21, which is higher than the SPY Sharpe Ratio of 0.70. The chart below compares the historical Sharpe Ratios of IRMD and SPY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

IRMD's dividend yield for the trailing twelve months is around 1.11%, less than SPY's 1.22% yield.

The maximum IRMD drawdown since its inception was -75.83%, which is greater than SPY's maximum drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for IRMD and SPY.

IRadimed Corporation (IRMD) has a higher volatility of 14.69% compared to SPDR S&P 500 ETF (SPY) at 4.86%. This indicates that IRMD's price experiences larger fluctuations and is considered to be riskier than SPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.